Cardinal Health, Inc.: stock overview

CAHNYSEHealthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Price

$281.10

November 13, 2026Market cap $65.4B

DCF calculator

What Ploutos Investor adds for Cardinal Health

Part of Ploutos Investor, €9.99 a month

See the plans

The full history: 17 fiscal years, from FY2010
The estimated fair value, with its range and its certainty
The full analysis, 18 a month
More questions to the chat on its filings
Excel with every year
An email when it reports, changes its dividend or an officer buys

In short

Cardinal Health had revenue of $258B over the last 12 months and net income of $1.8B, a net margin of 0.7%. Revenue grew by 9.4% a year on average over the last 5 years. At $281.10 the shares trade at a P/E of 36.0, against a median of 30.7 over the last 4 fiscal years. It has net debt of $3.6B. It pays a dividend yielding 0.73%.

From its SEC filings (latest fiscal year to June 30, 2026) and the price of November 13, 2026.

Its SEC filings

Market cap: $65.4B; 233M shares
P/E: 36.0; Today36.0
Median30.7
Revenue, 12 months: $258B; +9.4% a year over 5 years
Net margin: 0.7%; above 63% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+5.9% a year over 2 years

FY2026Jun 30, 202610-K
Revenue$254B
FY2025Jun 30, 202510-K
Revenue$223B
FY2024Jun 30, 202410-K
Revenue$227B

Year	Revenue	Net income	EPS	Free cash flow	Dividend per share	Price
FY2026Jun 30, 202610-K	$254B	$1.7B	$7.23	$4.5B	$2.04	$237.56
FY2025Jun 30, 202510-K	$223B	$1.6B	$6.45	$1.9B	$2.02	$168.00
FY2024Jun 30, 202410-K	$227B	$852M	$3.45	$3.3B	$2.00	$98.32

Fiscal years in figures

CAH's revenue, profit, cash flow and dividend with each year-end price, from FY2010 to FY2023, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $40.1B: $65.4B
Enterprise value: $68.9B
P/E 3-year median: 28.5: 36.0
EV / EBIT: 25.6
EV / Revenue: 0.3
P/B: –
FCF yield 3-year median: 8.2%: 7.5%
Earnings yield 3-year median: 3.5%: 2.8%

Profitability

Gross margin: 3.9%
Operating margin: 1.1%
Net margin 3-year median: 0.7%: 0.7%
ROIC: 35.7%
ROIC, 5-year average: 28.3%
ROE: –

Growth

Revenue, yearly change: +14.2%
EPS, yearly change: +12.1%
FCF, yearly change: +144.6%
Revenue, average a year: +9.4%
EPS, average a year: +28.3%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash: $5.3B
Total debt: $8.8B
Net debt: $3.6B
Net debt / EBITDA: 1.0x
Interest cover: 7.9x
Current ratio: 0.88

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 3-year median: 1.2%: 0.73%
Buybacks: 2.08%
Total returned: 2.81%
Shares, yearly change: -2.6%

Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 51).

Gross margin

3.7%

Above 29% of the 36 companies in its industry, and 4% of all.

Operating margin

1.0%

Above 49% of the 38 companies in its industry, and 37% of all.

Net margin

0.7%

Above 63% of the 39 companies in its industry, and 37% of all.

ROA

2.7%

Above 64% of the 38 companies in its industry, and 59% of all.

Revenue growth

-1.9%

Above 42% of the 39 companies in its industry, and 23% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

Contracts with the US government

What the federal government committed in contracts to the company and its subsidiaries, by federal fiscal year (October to September).

$523M Fiscal year 2025

In federal fiscal year 2025 (October 2024 to September 2025) the US government committed $523M in contracts to the company and its subsidiaries. The year before it was $683M. That is about 0.2% of its revenue in the fiscal year to June 30, 2025 ($223B), though an amount committed is not revenue.

Fiscal year 2022Oct 2021 to Sep 2022

$644M

Fiscal year 2023Oct 2022 to Sep 2023

$654M

Fiscal year 2024Oct 2023 to Sep 2024

$683M

Fiscal year 2025Oct 2024 to Sep 2025

$523M

Fiscal year 2026Oct 2025 to Sep 2026

$389M

From USAspending.gov, the federal government's public spending records, as of November 1, 2026. An amount committed is not revenue of the same year: a contract running several years counts when it is signed, and the company is paid as it does the work. The company is matched through the parent company the government records it under, which adds up its subsidiaries. A subsidiary recorded under another parent can be missing.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC: CARDINAL HEALTH INC
CIK: 721371
Exchange: NYSE
Industry (SIC): 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year ends: June 30
Latest annual report: June 30, 2026
Reporting currency: USD
Shares: 233M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

LLYEli Lilly and Company+0,00%

Compare with CAH
JNJJohnson & Johnson+0,00%

Compare with CAH
ABBVAbbVie+0,00%

Compare with CAH
UNHUnitedHealth+0,00%

Compare with CAH
MRKMerck & Company+0,00%

Compare with CAH
AMGNAmgen+0,00%

Compare with CAH
TMOThermo Fisher Scientific+0,00%

Compare with CAH
ABTAbbott Laboratories+0,00%

Compare with CAH

The Healthcare sector All companies

The full analysis

What do Cardinal Health's filings show?

These are Cardinal Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

A fair value range built from the filings
Earnings quality, debt and red flags
Insider and institutional moves
The case for and the case against

Questions about CAH

Didn't find what you were looking for?

Ask us

What is CAH's market cap?

Cardinal Health, Inc.'s market cap is $65.4B, at a price of $281.10 on November 13, 2026 and 233M shares.

What is CAH's P/E?

CAH's P/E is 36.0, on earnings per share of $7.82 over the last 12 months. The median over the last 4 fiscal years was 30.7.

How much revenue does CAH have?

Cardinal Health had revenue of $258B over the last 12 months. Over the last 5 years it changed by +9.4% a year on average.

Does CAH pay a dividend?

Yes. Cardinal Health paid $2.05 per share over the last 12 months, a yield of 0.73% at today's price. All the figures are in the Dividend section.

Where do the figures come from?

From Cardinal Health, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.